Alfred Williams

Dr. Alfred Williams

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Tetrahedron Letters
Verified
Journal Article
Closed access
SDSrinivasa Reddy Dandepally
Srinivasa Reddy Dandepally
AWAlfred Williams
Alfred Williams

11 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBSeoyeon Bok
Seoyeon Bok
DSDong Yeon Shin
Dong Yeon Shin
AYAlisha R. Yallowitz
Alisha R. Yallowitz
MEMark Eiseman
Mark Eiseman
MCMichelle Cung
Michelle Cung
MGMatthew B. Greenblatt
Matthew B. Greenblatt
Neurofibromatosis type I (NF1) is characterized by prominent skeletal manifestations caused by NF1 loss. While inhibitors of the ERK activating kinases MEK1/2 are promising as a means to treat NF1, the broad blockade of the ERK pathway produced by this strategy is potentially associated with therapy limiting toxicities. Here, we have sought targets offering a more narrow inhibition of ERK activation downstream of NF1 loss in the skeleton, finding that MEKK2 is a novel component of a noncanonical ERK pathway in osteoblasts that mediates aberrant ERK activation after NF1 loss. Accordingly, despite mice with conditional deletion of Nf1 in mature osteoblasts (Nf1fl/fl;Dmp1-Cre) and Mekk2−/− each displaying skeletal defects, Nf1fl/fl;Mekk2−/−;Dmp1-Cre mice show an amelioration of NF1-associated phenotypes. We also provide proof-of-principle that FDA-approved inhibitors with activity against MEKK2 can ameliorate NF1 skeletal pathology. Thus, MEKK2 functions as a MAP3K in the ERK pathway in osteoblasts, offering a potential new therapeutic strategy for the treatment of NF1.

9 March 2012 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AWAlfred Williams
Alfred Williams
VHValentine R. St. Hilaire
Valentine R. St. Hilaire
TLTina Lee
Tina Lee

21 November 2009 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
AWAlfred Williams
Alfred Williams
SDSrinivasa R. Dandepally
Srinivasa R. Dandepally
SKSharadsrikar V. Kotturi
Sharadsrikar V. Kotturi

8 January 2019 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
VHValentine R. St. Hilaire
Valentine R. St. Hilaire
WHWilliam E Hopkins
William E Hopkins
YMYenteeo S. Miller
Yenteeo S. Miller
SDSrinivasa R. Dandepally
Srinivasa R. Dandepally
AWAlfred Williams
Alfred Williams
The regioselective addition of Grignard reagents to mono- and disubstituted N-acylpyrazinium salts affording substituted 1,2-dihydropyrazines in modest to excellent yields (45–100%) is described. Under acidic conditions, these 1,2-dihydropyrazines can be converted to substituted Δ5-2-oxopiperazines providing a simple and efficient approach towards their preparation.